Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Fig. 3

GT-38 validation for Braak staging. GT-38 IHC staining of AD-tau pathology compared to the diagnostic standard antibody PHF1 detects NFTs to a similar extent, but fewer neuropil threads in CA1 regions of hippocampal tissue sections from cases of varying Braak stages (B0-B3) and AD-tau severity

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us